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In this review, we first revisit the original concept of “suppressorT-cells” in pregnancy, put
it in a historical perspective, and then highlight the main data that licensed its resurrec-
tion and revision into the concept of “regulatory T-cells” (Tregs) in pregnancy. We review
the evidence for a major role of Tregs in murine and human pregnancy and discuss Treg
interactions with dendritic and uterine natural killer cells, other players of maternal–fetal
tolerance. Finally, we highlight what we consider as the most important questions in the
field.
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ON THE RISE AND FALL OF SUPPRESSOR T-CELLS
IN (REPRODUCTIVE) IMMUNOLOGY
The history of immunosuppression in pregnancy started in the
1970s, just after the discoveries of Gershon and Kondo (1), when
transplantation and tumor immunologists devoted much work to
suppressor T-cells (Ts) and suppression. Since 1953, pregnancy
has been viewed as “Nature’s allograft” (2), the maternal immune
system being in direct contact with a semi-allogenic organism,
deeply engrafted and invasive, without, however, any sign of rejec-
tion. Medawar conceived three possible explanations for such a
paradox: (i) the uterus is an immunologically privileged site, (ii)
the fetus is an antigenically immature body, and (iii) there is a
non-specific immune depression of the mother, global or at the
maternal–fetal interface. As none of these three hypotheses later
proved to be correct, the search for an active phenomenon started.
Likewise, as recalled by Trowsdale and Betz (3), the discovery of
infectious tolerance by Gershon and Kondo awakened the search
for pregnancy-induced Ts. It was first shown that multiple syn-
geneic pregnancies of C57BL/6 female mice induced tolerance to
the male-specific H-Y antigen, as females showed delayed rejection
of male skin grafts expressing H-Y (4). A few years later, Simpson
et al. reported that multiparity induced a state of tolerance trans-
ferable by T-cells (5), and we demonstrated that allo-multiparity
evoked systemic T-cell tolerance or hypo-responsiveness to pater-
nal alloantigens (6). Importantly, there were no reports showing
that Ts could be involved in tolerance to the first allopregnancy,
leaving the question of maternal tolerance to fetal alloantigens
unanswered (except for a single unpublished but well-known study
by Baines, presented at the 1981 Bannf meeting).
The question of the specificity of a putative suppressive phe-
nomenon (or cells) was of importance, but inadequately answered
or even addressed, as Waldmann pointed out: “For example, on
the issue of “antigen specificity,” many of the early claims of
antigen-specific suppression lacked the discipline cultivated by the
classical serologists, in not performing criss-cross experiments. In
other words, to claim antigen specificity in a population of cells or
extracts thereof, one had to show that A-type T-cells primed to B
would suppress responses to B but not C, but also (and critically)
that A T-cells primed to C would suppress responses to C and not
B. This might easily have misled them into concluding specificity
on insufficient data!” (7).
In contrast, in their elegant human studies, Engleman et al.
reported that Ts induced by allopregnancy, and their soluble fac-
tors, were specific for both stimulator cells and responder cells in
mixed lymphocyte reactions (MLRs) (8, 9). They took advantage
of the rather rare existence of two multiparous twins, A and A′,
married to B and C. Ts from A suppressed an MLR of A and A′
against stimulator lymphocytes from B, but not C; conversely, Ts
from A′ suppressed an MLR of A and A′ against stimulator lym-
phocytes from C, but not B. None of the A or A′ T-cells could
suppress B anti-C or C anti-B MLR, nor those of an unrelated E
female against B or C.
Despite intense research in the field, the concept of Ts became
shaky in the early 1980s, mostly because the absence of a specific
marker for Ts prevented study of the functionality of pure popu-
lations of cells. The main data supporting the existence of Ts and
suppression were for a long time their linkage to an “I–J” or “I–C”
sub-region of the class II murine MHC loci, which were supposed
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to be coding for Ts as well as antigen-specific and non-specific sol-
uble suppressor factors. The “coup de grace” to the concept came
from the demonstration that these regions did not exist (10, 11).
For several years, the concept of suppression became politically
incorrect, with very few scientists “saying the S. . . word in public,”
to quote Green (12).
Nevertheless, without always explicitly mentioning Ts, several
studies continued to point to a form of regulation of maternal
immune status by T-cells during pregnancy. Some of them were
done in the now classic CBA x DBA/2J murine model of sponta-
neous immune abortion, in which it was shown pre-immunization
with BALB/c splenocytes had a protective effect and was trans-
ferable by T-cells (13, 14). To further investigate the mecha-
nisms underlying this protection, nine recombinant inbred strains
between BALB/c and DBA/2 were used for pre-immunization.
Only three strains behaved as BALB/c. However, when peripheral
lymphocytes from pre-immunized CBA females were used as puta-
tive regulatory cells in a CBA anti-BALB/c MLR, there was no cor-
relation between the presence of “suppression” and abortion rates,
suggesting that local intrauterine immunoregulation is the deter-
minant of success or failure of allopregnancy (15). Immunoregu-
lation was also supported by (i) reports that hypo-responsiveness
or tolerance to paternal antigens was repeatedly demonstrated in
multiple allopregnancy, with several studies pointing to an impor-
tant role of the seminal plasma (16–19) and (ii) the “Th1/Th2”
paradigm, e.g., a dominance of the production of Th2 cytokines
by the pregnant CBA/J (20–22) as well as the earlier demonstration
that in “responder” mice the allopregnancy-induced anti-paternal
alloantibody response is dominated by IgG1 (23).
ON THE REBIRTH OF SUPPRESSOR T-CELLS AS JUST
“REGULATORY” T-CELLS
In 1995, Sakaguchi and colleagues showed that elimination of
CD25+CD4+ T-cells elicits multi-organ autoimmunity, which
could be prevented by reinjection of the same cells (24, 25).
These properties would qualify CD25+CD4+ as Ts. Yet, the trauma
induced by the I–J story was probably so strong that they were given
the more “benign” denomination of regulatory T-cells (Tregs),
though they were cells endowed with suppressive activity.
The presence of the CD25 marker on the surface of these cells
enabled their negative or positive selection, and thus demonstra-
tion of their suppressive activity in various in vivo and in vitro
settings. However, as CD25 is not only constitutively expressed by
Tregs, but is also transiently expressed on activated T-cells, another
quantum leap for the biology of Tregs was the discovery of a more
specific marker, Foxp3, the master regulator of Treg development
and function (26). The understanding that mice and human beings
with a genetic defect in Foxp3 developed multi-organ autoimmune
diseases (27) sealed the case for the discovery of the long-sought
suppressor cells of immune responses.
ON REGULATORY T-CELLS AND MATERNAL–FETAL
TOLERANCE IN MICE
Treg DEPLETION INDUCES ABORTION IN MURINE PREGNANCY
These discoveries impacted reproductive biology, with the resur-
rection of the concept of T-cell-dependent immunoregulation.
We now know that Tregs are rapidly recruited to uterus-draining
lymph nodes and activated during the first day after embryo
implantation (28). These Tregs have the phenotype of acti-
vated/memory Treg subsets and are, at least in part, self-Ag
specific (28).
The functional importance of this recruitment has been high-
lighted by transfer/depletion experiments. Aluvihare et al. first
noted that Tregs increased markedly in all lymphoid organs
of C57BL/6 females mated with CBA males. Importantly, a
similar increase was observed whether syngeneic or allogeneic
matings were performed, suggesting that this was an alloantigen-
independent phenomenon. The cells obtained from B6 mice allo-
pregnant of CBA were able to suppress in vitro an MLR of B6
responder T-cells stimulated by CBA cells. However, and rather
surprisingly, third party stimulators,MLRs,were not tested for sen-
sitivity to suppression. The authors also transferred lymphocytes
from BALB/c females, either allopregnant from a C57BL/6 male
or syn-pregnant, into a nude BALB/c mouse subsequently mated
with a C57BL/6 male. Such a pregnancy proceeded normally if the
whole lymphocyte population was transferred, but the transfer
of lymphocytes depleted of CD25+ cells resulted in a high rate of
fetal resorptions, and T-cells massively infiltrated the implantation
sites. Interestingly, (i) both T-cells from syn- and allopregnant mice
were abortifacient for allopregnancy when depleted of CD25+ T-
cells and (ii) none of these two CD25-depleted populations caused
pregnancy problems in BALB/c syngeneic matings (29). These
results indicate that allospecific effector T-cells are responsible for
fetal rejection, but also that these allospecific effector T-cells do not
require prior exposure to MHC. Importantly, it should be noted
that the experimental setting is based on the transfer of T-cells
into a lymphopenic mouse, devoid of B- and T-cells. This induces
a major non-specific homeostatic proliferation and activation of
the transferred T-cells, and thus the setting does not fully reflect
immune regulation during physiological pregnancy.
We demonstrated that Tregs are involved in maternal–fetal
tolerance using a more physiological setting by directly deplet-
ing/inhibiting CD25+ cells in vivo in pregnant mice, without any
further cell manipulation (30). We showed that treatment with
anti-CD25 antibodies did not affect syn-pregnant BALB/c mice,
but induced fetus resorption in BALB/c allopregnant females. Inci-
dentally, it should be noted that in all the experiments reported, it
was not tested whether elimination of Tregs affected primarily, or
exclusively, male (H-Y+) fetuses – see Kahn and Baltimore (31).
Treg EXPANSION/ACTIVATION OR TRANSFER REDUCES ABORTION IN
MURINE PREGNANCY
Zenclussen and co-workers have extensively used the CBA x
DBA/2J model of naturally occurring murine spontaneous abor-
tion (32–35), initially described by us in 1983 (13). The authors
claimed that they were able to “completely prevent” abortion in
CBA x DBA/2J mice by transferring Tregs from alloimmunized
mice, reporting also “no abortion” at all in the controls CBA
x BALB/c and CBA x CBA (32–34). They also deduced antigen
specificity from the “complete protection against abortion” (0%)
obtained by transferring Tregs from BALB/c-mated CBA/J females,
but not those from C57/BL6-mated CBA/J females. Furthermore,
transfer of Tregs from the CBA/J x CBA/J mating combination
was also protective, which is rather surprising in terms of antigen
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specificity (35). These results are puzzling since every mammal
species (murine strains included) have a strain-specific abortion
rate (see, for example, the records of the Jackson laboratory),
depending notably on genetic chromosome anomalies, most of
them occurring as a consequence of meiosis.
More recently, the same authors showed that Treg-transferred
CBA/J females treated with anti-IL-10 – but not anti-TGF-ß –
prior to mating with DBA/2J males had an increased abortion
rate (36). In this line, we have reported that anti-IL-10 treatment
selectively affects CBA x DBA/2J mating, but not other mating
combinations (22).
We investigated whether in vivo Treg expansion/activation
could improve successful pregnancy rates. We observed that Treg
stimulation, either directly by low-dose IL-2 or indirectly by Fms-
related tyrosine kinase 3 ligand, led to normal pregnancy rates in
CBA x DBA/2J abortion-prone mice (28).
Conversely, high doses of intravaginal interferon have been
shown to be abortifacient and/or anti-implantation not only
because of their classic effects in conjunction with TNF but also
by reducing Tregs and IL-17 at the implantation site (37).
Treg CHANGES DURING THE ESTROUS CYCLE
A further case for an important role of Tregs in pregnancy is
the observation that the uterus “prepares” itself for pregnancy by
specific cyclic accumulation of Tregs (38, 39).
Kallikourdis et al. studied changes in the numbers of T-cells
in the uterus together with the expression levels of chemokines
known to induce Treg migration. A rise for CCL3, CCL4, CCL22,
and CX3CL1 was noted from diestrus to estrus. If mating led
to pregnancy, only CCL4 remained high. In fact, there was a
direct correlation between uterine CCL4 expression and Foxp3+
T-cells. Moreover, from estrus to gravid uterus, CCR5+ cells rose
from 50% to more than 70%. The authors concluded that since
“alloantigen-experienced effector Tregs” express CCR5, CCL4
might be responsible for the retention of these cells in the gravid
uterus (39).
Hormonal changes may be drivers for Treg changes. In par-
ticular, estrogen has been shown to induce expansion of Foxp3+
cells (40, 41), including in the (pregnant) uterus (42). Analyses of
Treg suppressive activity in wild-type, estrogen receptor knockout
(ERKO), and programed death-1 (PD-1) KO mice, revealed that (i)
estrogen induces PD-1 in CD4+Foxp3+ cells and (ii) PD-1 expres-
sion as well as Treg suppressive activity was reduced in estrogen
receptor KO mice. Pre-treatment of PD-1 KO mice with estrogen
led to a partial recovery of Treg suppression without enhancing
Foxp3 expression. Yet, PD-1 is likely not the only pathway con-
trolling Treg activity, since Treg function is also partly restored
by estrogen in PD-1 deficient animals (43). Thus, both PD-1-
dependent and PD-1-independent pathways could be involved
in estrogen-mediated Treg suppressive activity. Estrogen has also
been shown to directly influence Treg expression of IL-10 (44).
An increase of Tregs in mice at day 2 of pregnancy has been
described, except for the CBA x DBA/2J mating combination
(45), which led to the conclusion that Tregs do not depend on
hormonal levels. This is in disagreement not only with the afore-
mentioned reports but also with the data of Mao et al., who showed
an increase in Tregs in mid-pregnancy, which is at least in part
progesterone-dependent and correlates with an increase in IL-10
production by Tregs (46).
The human chorionic gonadotropin (hCG) has been reported
to attract Tregs locally in the murine uterus (47, 48). Similarly,
as mentioned before, the luteinizing hormone (LH) has been
reported to completely prevent abortion in the classic CBA x
DBA/2J murine model of immune abortion, which correlated with
increased Treg numbers both locally and at the periphery (45).
THE INFLUENCE OF MATING/SEMINAL FLUID ON Tregs
Events occurring early during pregnancy seem to influence future
Treg expansion/function. Using several murine models, Robert-
son’s group demonstrated that mating itself is important for
successful pregnancies, with the seminal plasma driving the imme-
diate and preparing the future expansion of uterine and, likely,
systemic Tregs. This induces a (transient) “tolerance-like” state to
paternal alloantigens in mice. Moreover, the authors showed that
seminal fluid contains both TGF-β and prostaglandin E, which
potently induces Tregs (49, 50).
ON REGULATORY T-CELLS IN HUMAN PREGNANCY
In human beings, Saito’s group identified decidual Foxp3+ Tregs
in uterine biopsies (51, 52). Robertson’s group showed the pres-
ence of Foxp3 mRNA in the uterus of normal women by qRT-PCR
in endometrial biopsies obtained during the mid-secretory phase
of the menstrual cycle. Interestingly, they found that Foxp3 mRNA
levels decrease two-fold in patients with primary unexplained
infertility compared with fertile women (53). However, they could
not correlate this result with endometrial cytokine levels (TGF-
β1, TGF-β2, TGF-β3, IFN-γ, IL-2, IL-4, IL-5, IL-10 and IL-12p40,
IL-1α, IL-1β, IL-6, LIF, GM-CSF, and TNF-α) (53).
Fainboim and colleagues monitored Tregs in the menstrual
cycle of fertile and infertile women (54) and showed a periodic
modulation of Tregs. Treg levels peaked in the late follicular phase,
which correlated with serum estradiol, and decreased markedly in
the luteal phase. Interestingly, they also showed that in patients
with recurrent spontaneous abortions (RSAs), Tregs were low and
changes in Treg numbers in the follicular or luteal phase were not
significant. Treg numbers in women with RSAs were very similar to
the numbers observed in post-menopausal women (54). Further-
more, when these Tregs were tested for their suppressive capacity,
a higher number of cells was required to obtain the same level of
suppression as Tregs from fertile women, suggesting that, in RSA
patients, Tregs are functionally defective (54).
Likewise in mice, the influx of Tregs in the decidua is not only
dependent on the hormonal levels in the environment but is also
linked to the intercourse, which temporarily increases their num-
ber (50). In RSA, the reduction of Tregs appears not to be related to
the reduced levels of IL-6 and rIL-1α mRNAs. On the contrary, the
relative abundance of mRNAs encoding for LIF, GM-CSF, IFN-γ,
IL-1β, IL-4, IL-5, IL-10, IL-12p40, TNF-α, TGF-β1, TGF-β2, and
TGF-β3 remained unaltered regardless of the fertility status (53,
55). In this context, IL-27 has recently been suggested to regulate
Tregs, IL-17, and IL-10 expression (56).
Besides hormones and cytokines, trophoblasts can also recruit
and induce Tregs. The high levels of TGF-β produced by tro-
phoblasts both induce and recruit CD4+ peripheral Tregs (pTregs)
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in vitro. Trophoblasts can also activate some CD8+ regula-
tory cells, which are independent of MHC class I, have a
restricted TCR repertoire, and co-express the mucosal markers
CD103 and CD101 (57). In the blood of pregnant women, they
rapidly expand, suggesting a potential role for these cells in vivo.
Despite extensive evidence of their role in regulating immune
responses – see for example (58–60) – the role of the CD8+
Treg subset in pregnancy or embryo implantation is still poorly
understood.
Regulatory T-cells may also be involved in pre-eclampsia (PE),
together with regulatory NK T-cells (52, 61, 70, 71), as reported
by several authors (62–65), except for Paeschke et al. (66). Fur-
thermore, it has been suggested that there might be an imbal-
ance between CD4+CD25hiFoxp3+ and CD4+CD25−Foxp3+
Treg subsets in PE (61). Recently, however, not only Tregs
but also HLA-G+CD4+ T-cells have been suggested to play a
role (65).
ON REGULATORY T-CELL SPECIFICITY IN PREGNANCY
The studies discussed so far point to an interesting problem: what
is the specificity of Tregs mobilized for successful pregnancy?
This question was recently addressed by Rowe and colleagues,
who showed that pregnancy primes the selective accumulation
and activation of maternal Tregs with fetal specificity (67). The
authors employed transgenic mice that expressed a surrogate fetal
antigen, the I-Ab 2W1S55–68 peptide. They found that pregnancy-
induced maternal CD4+Foxp3+ cells specific for I-Ab 2W1S55–68,
a peptide that expressed CD44 and rapidly accumulated during
mid-gestation. These cells persisted at levels increased approxi-
mately 10-fold through day 100 post-partum. The same maternal
Tregs with fetal specificity expanded at an accelerated rate during
secondary pregnancy with the same partner. Using the Foxp3-
DTR model (68), the authors also demonstrated that the expanded
cells were pTregs and that partial ablation of Tregs in Foxp3-
DTR/WT mice resulted in reduced fetal abortion rates compared
with primary pregnancy (67).
In pregnant mice, a reduced number of paternal antigen-
specific T-cells (69), likely due to peripheral clonal deletion (70),
and a reduced responsiveness to tumors bearing the same paternal
antigen (T-cell awareness of pregnancy), was demonstrated using
a transgenic mouse model and a weakly antigenic tumor allograft
challenge. This was interpreted as implying that multiple tolero-
genic mechanisms are at play at the same time. T-cell phenotype
and responsiveness to tumors was restored after delivery (69).
This questions the antigen specificity of pregnancy-induced
Tregs. In the aforementioned system, it has been shown using
MHC tetramer that Tregs are not themselves Ag specific, but
mediate antigen specificity by locally anergizing the highly specific
effector T-cells (67, 69–73).
However, the existence of “true” antigen specificity of Tregs
involved in maternal–fetal tolerance is claimed in several stud-
ies in human beings (54, 74) and in mice (31, 35, 36, 75). In the
classic CBA x DBA/2J murine resorption model, Treg function has
been shown to be elicited by the paternal-specific“protective”pep-
tide (76). Similarly, the data of Kahn and Baltimore in an elegant
transgenic system support specificity in the regulation of anti H-Y
responses (31).
In contrast, we find in the very same model that Treg expan-
sion is driven, at least in part, by recognition of self-specific
antigens (28).
This apparent contradiction could be solved if in the uterus and
draining lymph nodes two different Treg subsets were mobilized
at implantation and later throughout pregnancy, one being self-
specific, the other being fetus-Ag or MHC-specific. As reviewed by
Marrack et al. in “T-cells and their eons-old obsession with MHC”
(77), T-cells could be both antigen- and MHC-specific and thus
self-biased. The different loops created by the germline-encoded
and non-germline portions of the TCR may contact the MHC
proteins and the peptide bound on the MHC, respectively. This
idea comes from the observation that there are many TCR vari-
able elements that form specific patterns to contact a particular
site on the MHC. Mutations in these sites affect the ability of T-
cells to react with the MHC. Interestingly, these similar elements
were found in evolutionarily distant species, such as sharks and
human beings, suggesting that they evolved to allow TCR to react
with MHC proteins.
ON REGULATORY T-CELLS IN EVOLUTION:
THE DEVELOPMENT OF THYMIC AND PERIPHERAL Tregs
AND THEIR ROLE IN MATERNAL–FETAL TOLERANCE
Placentae appeared very early, and reappeared at various stages
during evolution. Velvet worms – onychophora – are placen-
tal viviparous, as are sharks and other fishes, some dinosaurs
and reptiles, too. Placentation in eutherian mammals came later
as the first mammals, the monotremes, are oviparous. The pla-
cental mammals emerged 165–80 million years ago (the oldest
known eutherian fossil so far being 160 million years old, the
Juramaia sinensis (78), which fits with most DNA clock analysis
of the separation between eutherians and marsupials. The first
well-documented placental eutherian is the 65-million-year-old
Maelestes gobiensis (79).
The first viviparous mammals, in between dinosaurs and mam-
mals, were faced with the development of a sophisticated adaptive
immune system, a challenge not previously present. Marsupials
escaped the threat of fetus rejection just before it appeared by
using the marsupial pouch to house the quasi-fetus newborn. The
development of placentation in eutherians involved a series of sup-
pressive mechanisms. Only a few of them have been demonstrated
to be crucial, including those involving Tregs.
Thymic Tregs (tTregs) differentiate in the thymus following
up-regulation of Foxp3 as a consequence of their expression of
self-antigens highly reactive TCRs. pTregs generate in the periph-
ery upon stimulation with high-affinity cognate TCR ligands in
the presence of TGF-β and retinoic acid (80–83). The observa-
tion that CNS1 – an intronic Foxp3 enhancer containing Smad3 –
and retinoic acid receptor (RAR)-binding sites facilitate TGF-β-
dependent Foxp3 induction and pTreg cell differentiation, but
is dispensable for tTreg generation, suggests that the biological
functions of these two Treg cell subsets are distinct (84).
Samstein and co-workers generated CNS1-deficient mice (85),
which lack only pTreg cells but not tTregs. They observed that preg-
nancy in these mice resulted in a high abortion rate in allogeneic,
but not syngeneic matings. Moreover, ablating tTregs in the CNS1-
deficient mice did not enhance allopregnancy abortion (85).
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Hence, they concluded that pTregs are necessary for successful
pregnancy while tTregs are dispensable.
The CNS1 non-coding sequence does not exist in other phyla,
such as non-mammals, and in mammals is present only in euthe-
rians, but not in marsupials. Thus, Samstein and co-workers
concluded that “the mechanism of extrathymic differentiation of
pTreg cells may have been gained during evolution to reinforce
tolerance to paternal alloantigens presented by the fetus dur-
ing the increasingly long gestation period in placental mammals”
(85). However, the authors also reported a defect in spiral artery
formation in mice lacking pTregs, which open other possibility
than just tolerance for the role of pTregs in pregnancy.
We believe that the unique role of pTregs should be balanced
by the fact that there exist yet no models of a pure tTreg depletion,
which could demonstrate the role – or absence of role – of this sub-
set in maternal–fetal tolerance. Furthermore, two gestational peri-
ods should be considered: the embryo implantation period and
later fetus development. We showed that the immediate response
of the immune system to embryo implantation is mediated by acti-
vated/memory self-specific Tregs, hence tTregs. It is thus possible
that tTregs initiate a tolerance state that is later maintained with
the recruitment of pTregs. We believe that both tTregs and pTregs
have been selected during evolution primarily for the purpose of
establishing maternal–fetal tolerance in eutherians (28, 85).
ON SIMILARITIES BETWEEN REGULATORY T-CELL
RESPONSES TO FETAL AND TUMOR GROWTH
As often mentioned in the literature since the dawn of Reproduc-
tive Immunology, there are striking similarities between malignant
processes and pregnancy (86). In a tumor model, we observed
that tumor emergence elicits a brisk Treg response that pre-
cedes and preempts the response of effector T-cells. This Treg
response is detectable as soon as days 2–3 post-tumor cell
implantation or emergence and is mediated by self-antigen-
specific CD44hiCD62low activated/memory Tregs (87). We recently
reported striking similarities in the Treg response to embryo
implantation, with the same recruitment of self-antigen-specific
CD44hiCD62low activated/memory Tregs detectable within 2 days
post-implantation (28).
However, the parallel is not complete. Pre-immunization
against an artificial paternal antigen (HA in our case) only
marginally increased fetal loss, whereas pre-immunization with
the HA antigen resulted in 100% eradication of HA-expressing
tumors. However, mixing Treg depletion with pre-immunization
drastically increased fetal loss (28).
Furthermore, the immunological paradox of pregnancy,
whereby the maternal immune system tolerates the presence of
the semi-allogenic fetus, has historically been associated with the
early work on immunological tolerance to transplantation. How-
ever, even though Tregs play a role in the control of allogeneic
responses to solid or cell grafts (including allogeneic cancer cells)
(88) and have demonstrated therapeutic potential in this setting
(89), these grafts are always rejected in the absence of specific inter-
vention. This highlights the uniqueness of the immune responses
in the allogeneic maternal/fetal tolerance setting.
We hypothesized that the similarities in the Treg response to
tumor or embryo implantation suggest that protection of cancer
cells by Tregs became the price paid for an efficient protection of
embryos (28).
ON OTHER IMPORTANT CELLS
The decidua is populated by several immune cell types, which
coexist together with stroma cells and trophoblasts. Among them,
dendritic cells (DCs) and uterine NK (uNK) cells are highly abun-
dant. During the female estrus cycle and throughout pregnancy,
the number of these cells undergoes dramatic chances, as do, likely,
their reciprocal interactions. The concept of decidual cell–cell
interactions is relatively new and arises from an important fea-
ture of immune cells, their ability to migrate, which confers them
dynamic properties. The introduction of intravital two-photon
microscopy made it possible to study the dynamic behavior of
immune cells and their interactions, in a spatio-temporal dimen-
sion. However, information about immune cell dynamics at the
maternal–fetal interface remains limited, while abundant in other
models such as cancer, infection,or inflammation [reviewed in Ref.
(90)]. T-cells are relatively rare in the uterus of both pregnant and
non-pregnant human beings and mice (91, 92). However, despite
their paucity, Tregs are critical for normal pregnancy. The secret
of their pivotal role could thus reside in the dynamic interactions
they establish within the decidua.
UTERINE NK CELLS
Uterine NK have long been considered the most important cell
type for the success of pregnancy due to their abundance in the
decidua. Moreover, as increasing evidence points to the impor-
tance of other leukocytes, such as Tregs, the functional relationship
between uNK cells and the other immune cells has come into focus.
Uterine NK cells differ from NK cells in other sites of the
body. Mature uNK contain numerous granules (rich in perforin,
granzymes, granulysis) (93), but, unlike peripheral blood NK cells,
uNK cells are only weakly cytotoxic in vitro and do not kill
trophoblasts in vivo. They seem to both differentiate and pro-
liferate in the uterus, but also migrate from the periphery (94,
95). In mice, uNK increases upon implantation in concomitance
with trophoblast invasion of the endometrium and subsequent
decidualization (96) and they peak at mid-gestation. Mouse uNK
cells have been shown to localize in the mesometrium to form
a characteristic ring-shaped structure around the spiral arteries
characterized by the presence of highly proliferative cells, called
the mesometrial leukocyte aggregate of pregnancy, MLAp (97).
Even though models of artificial decidualization have shown that
uNK differentiation depends on hormonal changes (98), rather
than on trophoblast invasion, mouse uNK cells do not express
progesterone receptor (96).
Early implantation sites in mice deficient for NK, T-, and B-cells
showed abnormal decidual and mid-gestational myometrial struc-
tures and no spiral artery modifications (99–101). Noteworthy,
despite these defects, litters of normal size were born (102–105),
except in the Tge26 (100, 101) mice, which display a reproductive
deficit. Bone marrow transplantation of NK+ T−B−pools before
mating restored the defects suggesting a major role of uNK cells
more related to vascularization than to tolerance.
In this line, human pregnancy-associated disorders, such as
PE, still birth, and fetal growth restriction, all display deficits in
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spiral artery formation and are characterized by a “shallow inva-
sion” of the uterine wall (106, 107). uNK cells produce several
angiogenic factors (108–110) such as IFN-γ, and Croy and col-
leagues have shown that artery remodeling is strictly dependent
on IFN-γ produced by NK cells in the uterus (111, 112). How-
ever, in human beings, the levels of IFN-γ during pregnancy are
rather low although spiral artery remodeling remains crucial (113,
114). Trophoblasts express a characteristic combination of HLA-
C, HLA-G, and HLA-E MHC class I molecules (115) and correct
spiral artery remodeling has been correlated to allo-recognition of
trophoblasts cells by uNKs.
UTERINE DENDRITIC CELLS
Together with uNK cells, DCs represent the most abundant cell
type in the uterus. They are known as potent antigen-presenting
cells (APC). DCs have been reported to recognize foreign anti-
gens present on sperm cells upon mating (49, 50, 116), but
most likely also recognize alloantigens expressed by the invasive
trophoblasts during implantation and decidualization. Interest-
ingly, upon implantation, DCs re-localize to different areas of the
decidua (117). In particular, Erlebacher and co-workers have sug-
gested that the decidua works as a barrier that impedes DCs to
efficiently prime T-cells in the lymphoid organs, to minimize the
immune response to paternal alloantigens (118). Furthermore,
they described how DCs remain entrapped in the uterus and are
unable to carry antigens to the lymph nodes due to the lack of lym-
phatic vessels, which, in the mouse uterus, are confined exclusively
to the myometrium (118, 119). Importantly, they demonstrated
the spatio-temporal regulation and the extent of antigen-specific
T-cell priming during pregnancy (120). They mated wild-type
FIGURE 1 |Tregs in mouse pregnancy. Thymic Tregs (tTregs) recognizing
maternal/fetal self-antigens differentiate in the thymus from the CD4+ T-cell
precursors by up-regulating Foxp3 expression. During the estrus cycle, there
is an increase in tTregs in the periphery and the uterus where, together with
tolerogenic dendritic cells (tDC) and uterine NK (uNK) cells, they prepare a
uterine tolerogenic environment for pregnancy under a hormonal control.
During the estrus phase, recruitment of tTregs at ovulation is maximum in
order to prepare a tolerogenic uterine environment for a potential embryo
implantation. During pregnancy, self-antigen-specific activated/memory tTregs
mount a first-line tolerogenic response (28). Later, the first fetal/paternal
alloantigens generated by fetal cells trigger an immune response to paternal
alloantigens (85). Alloantigen presentation through tDCs favors the conversion
of naïve CD4+ T-cells in induced peripheral Tregs (pTregs) by up-regulating
Foxp3 and its Cigs1 enhancer gene expression (84). The clonal expansions of
allospecific pTregs together with the proliferation of tTregs, uNKs, and tDCs
during the mid-gestation periods ensure the maintenance of immune
tolerance to the fetus and allow vascularization to guarantee a steady supply
of nutrients and oxygen to the fetus for a proper growth and development.
Generation of memory pTregs specific for paternal antigens will contribute to
tolerance induction to the same fetal/paternal alloantigen exposure in case of
a secondary pregnancy with the same paternal antigens. The tTregs, uNKs,
and tDCs cross-talk is yet poorly defined.
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females with Act-mOVA males, where OVA expressed by the con-
ceptus mimics a paternal-specific antigen. Only DCs of maternal
origins presented OVA-MHC in the LNs and induced OVA-specific
T-cell expansion at mid-gestation, suggesting that the LNs are the
primary site of alloantigen-presentation.
Finally,uterine DCs have also been proposed to perform trophic
functions. Plaks and co-authors induced fetal loss by depleting
DCs before implantation (121) using the CD11c-DTR transgenic
mouse model (122). The absence of DC-derived angiogenic factors
hampered vessels’ formation, and affected normal implantation
and decidualization. Taken together, these results indicate that
during mouse pregnancy, DCs prime T-cells and play a trophic
function by ensuring correct vessel formation.
ON Treg CROSS-TALKS
Similar to Tregs, uNK cell numbers vary during the estrus cycle.
Recent results from Rudensky’s group have highlighted a defect
in spiral artery formation in mice lacking pTregs (85). Absence of
pTregs determines fetal demise in their model. These results pose
an interesting question: is there co-operation between uNK cells
and Tregs to ensure correct spiral artery modification?
Moreover,Rowe and colleagues have recently shown that mater-
nal Tregs specific for paternal alloantigens expand> 100 folds dur-
ing pregnancy (67). These cells persist after delivery and, because
of their antigen-specific memory, expand faster than naïve Tregs
in subsequent pregnancies, possibly contributing the well-known
“lymphoid recall flare” in second pregnancy (123). Relating these
results to the human situation, the authors suggest that their obser-
vations might explain why the rates of pregnancy complications,
such as PE, decrease in subsequent pregnancies. Taken together,
both in human beings and mouse, uNK cells and Tregs seem
to affect spiral artery formation with important consequences
for fetal survival. Moreover, Tregs can also suppress NK cells.
uNK cells in turn might control Treg recruitment to the pregnant
uterus.
Furthermore, DC maturation in the pregnant uterus is thought
to support expansion of antigen-specific Tregs that finally protect
the fetus from abortion (49). Thus, DCs have been proposed to
exert a dual role in promoting tolerance to paternal alloantigens,
limiting their own priming-activity, also in response to signals in
the microenvironment, and priming the few Tregs present in the
decidua.
Finally, the known cross-talk between NK cells, DCs, and Tregs
may be operating locally in the uterus during pregnancy (124).
ON BURNING QUESTIONS
Since the discovery of Tregs 30 years ago, our knowledge about
immune tolerance has dramatically improved. The data summa-
rized above suggest their important role in conserved mecha-
nisms that establish and maintain immune tolerance during early
pregnancy (Figure 1).
We believe that most important points for the field that remain
unanswered or controversial are: (i) the antigen specificity of Tregs
involved, which could be elucidated by TCR deep-sequencing,
(ii) the respective functional role of the Treg subsets involved
(i.e., tTreg, pTreg, etc.), (iii) the localization and functional cross-
talk of Tregs with uNK and uDCs, which could be studied by
intravital imaging and novel transgenic mice (125–127), and
(iv) the link between Treg responses to embryo and tumor cell
implantation.
A better understanding of these mechanisms will be pivotal in
identifying more effective therapeutic targets for the treatment of
pathological conditions related to pregnancy (128, 129) and, more
generally, to diseases in which the immune balance is perturbed.
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